Prostate Cancer Susceptibility Candidate (PRAC) Peptide
PRAC
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN937516
Quick Overview for Prostate Cancer Susceptibility Candidate (PRAC) Peptide (ABIN937516)
Target
PRAC
(Prostate Cancer Susceptibility Candidate (PRAC))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- DQGPAHLTTS KSAFLSNKKT STLKHLLGET RSDGSACNSG ISGGRGRKIP
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PRAC antibody,
Alternative Names: PRAC control peptide, PRAC antibody Blocking Peptide, Anti-PRAC Blocking Peptide, prostate cancer susceptibility candidate Blocking Peptide, C17orf92 Blocking Peptide, MGC32520 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- PRAC (Prostate Cancer Susceptibility Candidate (PRAC))
-
Background
- This gene is reported to be specifically expressed in prostate, rectum and distal colon. Sequence analysis suggests that it may play a regulatory role in the nucleus.
-
Molecular Weight
- 6 kDa
Target
-
You are here:
